Monday, December 4, 2023

Canada’s Politics and Government News Source Since 1989

Monday, December 4, 2023 | Latest Paper

TRENDING:

Proposed PMPRB regulations requires focused dialogue with all players

Canada needs an approach that balances pricing considerations with the need to encourage investment, foster innovation, and most of all, ensures Canadians have timely access to the most innovative, life-saving new medicines.

Opinion
BY PAMELA FRALICK
February 17, 2022

Opinion | BY PAMELA FRALICK | February 17, 2022

More Opinion

Come on! Dial down the nonsense in the House before it’s too late

OpinionBY EDITORIAL

Poilievre continues to place Trudeau on Canada’s ‘most unwanted’ list and his strategy appears to be working

Good news story gets buried in anti-Trudeau wave

OpinionBY SHEILA COPPS

Transitioning to a low-carbon world is one of the great game-changing challenges of our generation, but Liberals have failed to sell it

OpinionBY DAVID CRANE

Catalyzing the opportunity of the North Pacific green corridor

OpinionBY IAN ANDERSON

Related Stories

Canada must renew leadership on antimicrobial resistance

OpinionBY DANI PETERS, PAMELA FRALICK, & MICHAEL HODIN

Turning crisis into opportunity: a Canadian-made bio-revolution

OpinionBY BETTINA HAMELIN

New drug pricing rules on Canada Day will end years of damaging uncertainty for industry and patients

OpinionBY JASON FIELD

Will the government stop the changes to PMPRB?

OpinionBY DOUG EARLE

Canada’s life sciences sector: its time has come

OpinionBY ALAN BERNSTEIN